The mannose-6-phosphate/insulin-like growth factor 2 receptor (Man-6-P/IGFII receptor) is involved in lysosomal enzyme sorting, IGFII degradation and pro-TGFbeta activation. Genetic alterations in hepatocarcinomas and a few breast cancers suggest that this receptor behaves as a tumor suppressor. Mor
โฆ LIBER โฆ
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas
โ Scribed by Chappell, SA; Walsh, T; Walker, RA; Shaw, JA
- Book ID
- 109837472
- Publisher
- Nature Publishing Group
- Year
- 1997
- Tongue
- English
- Weight
- 891 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Stable amino-acid sequence of the Mannos
โ
Jean-Marc Rey; Charles Theillet; Jean-Paul Brouillet; Henri Rochefort
๐
Article
๐
2000
๐
John Wiley and Sons
๐
French
โ 143 KB
๐ 2 views
Failure to detect genetic alteration of
โ
Ikuo Wada; Hiroaki Kanada; Kimie Nomura; Yo Kato; Rikuo Machinami; Tomoyuki Kita
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 135 KB
๐ 1 views
The mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) suppresses cell growth through binding to the insulin-like growth factor 2 (IGF2) and latent complex of the transforming growth factor-โค (TGF-โค). Recently, it was reported in the United States that loss of heterozygosity (LOH)